Home | Coverage | Agents | Pulse | LogIn |
Darwin Score | +5 |
Ticker | CERT |
Latest Price | 11.33 USD as of close on 03-Jul-2025 |
3 Month price range | 9.05 to 14.47 USD |
Market Capitalisation | 1.84Bn USD |
Country | United States of America |
Region | North America |
Economic Sector | Health Care |
Business Sector | Health Care Equipment & Services |
Industry | Health Care Technology |
Sub-Industry | Health Care Technology |
Description | Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara I See More ... |
Company URL | https://www.certara.com |
See Darwins Full Analysis for Certara Inc |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Certara Inc. Further information and full detail is available when you login.
TMA Part | Focus of Analysis | TMA Score |
---|---|---|
Price | Analysis of performance, trend, RSI, OBV and moving averages | +18 |
Sentiment | News and Candle Patterns. | 0 |
Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +2 |
Flow | Institutional, Fund and Insider buying and selling. | 0 |
Models | Forecast models. | -15 |
There are 4 live alerts for Certara Inc.
There are 4 peers of Certara Inc.
Asset Name | Industry Group | Perf(20d)% | Asset Score |
---|---|---|---|
HealthStream Inc (HSTM) | Health Care Technology | -2.0 | +17 |
Omnicell Inc (OMCL) | Health Care Technology | -4.6 | +7 |
Schrodinger Inc (SDGR) | Health Care Technology | -11.0 | -2 |
Simulations Plus Inc (SLP) | Health Care Technology | -35.6 | -15 |
To see complete information on Certara Inc or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
©2025 Darwin Knows - All Rights Reserved |